Temat: "Pulmonary Disease, Chronic Obstructive" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Immunomodulatory effect of N-acetyl-seryl-aspartyl-proline and vasoactive intestinal peptide on chronic obstructive pulmonary disease pathophysiology.
Autorzy:: Cai J; Department of Emergency, The Second Hospital of Shandong University, Jinan City, China.
Chen Q; Department of General Surgery and Critical Care Unit, Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine Chongming Brangch, Shanghai, China.
Mehrabi Nasab E; Department of Cardiology, School of Medicine, Tehran Heart Center, Tehran University of Medical Sciences, Tehran, Iran.
Athari SS; Department of Immunology, School of Medicine, Zanjan University of Medical Sciences, Zanjan, Iran.; Pokaż więcej
Źródło:: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2022 Dec; Vol. 36 (6), pp. 1005-1010. Date of Electronic Publication: 2022 Jul 04.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Disease, Chronic Obstructive*/drug therapy
Vasoactive Intestinal Peptide*/pharmacology
Oligopeptides*/pharmacology
Animals ; Mice ; Anti-Inflammatory Agents/pharmacology ; Cytokines ; Fibrosis ; Inflammation ; Superoxide Dismutase

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Risk factors and natural history of parastomal hernia after radical cystectomy and ileal conduit.
Autorzy:: Ghoreifi A; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Allgood E; Department of Radiology, University of Southern California, Los Angeles, CA, USA.
Whang G; Department of Radiology, University of Southern California, Los Angeles, CA, USA.
Douglawi A; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Yu W; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Cai J; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Miranda G; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Aron M; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Schuckman A; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Desai M; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Gill I; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Daneshmand S; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.
Duddalwar V; Department of Radiology, University of Southern California, Los Angeles, CA, USA.
Djaladat H; Institute of Urology, Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, CA, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2022 Sep; Vol. 130 (3), pp. 381-388. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji:: Journal Article
MeSH Terms:: Diabetes Mellitus*
Incisional Hernia*/epidemiology
Incisional Hernia*/etiology
Pulmonary Disease, Chronic Obstructive*
Urinary Bladder Neoplasms*/etiology
Urinary Bladder Neoplasms*/surgery
Urinary Diversion*/adverse effects
Cystectomy/adverse effects ; Cystectomy/methods ; Female ; Hernia/etiology ; Humans ; Retrospective Studies ; Risk Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Relationship between rosacea and chronic obstructive pulmonary disease: Rosacea and comorbidities: Rosacea and comorbidities.
Autorzy:: Demirbaş A; Department of Dermatology, Evliya Çelebi Training and Research Hospital, Kütahya Health Sciences University, Kütahya, Turkey.
Yümer Y; Department of Pulmonary Diseases, Konya Numune Hospital, Konya, Turkey.
Elmas ÖF; Department of Dermatology, Kırıkkale University, Kırıkkale, Turkey.
Ulutaş Demirbaş G; Department of Dermatology, Evliya Çelebi Training and Research Hospital, Kütahya Health Sciences University, Kütahya, Turkey.
Atasoy M; Department of Dermatology, Kayseri City Hospital, Health Science University, Kayseri, Turkey.
Türsen Ü; Department of Dermatology, Mersin University, Mersin, Turkey.
Dursun R; Department of Dermatology, Necmettin Erbakan University, Konya, Turkey.
Lotti T; Department of Dermatology, Guglielmo Marconi University, Rome, Italy.; Pokaż więcej
Źródło:: Journal of cosmetic dermatology [J Cosmet Dermatol] 2022 May; Vol. 21 (5), pp. 2255-2262. Date of Electronic Publication: 2021 Aug 19.
Typ publikacji:: Journal Article
MeSH Terms:: Pulmonary Disease, Chronic Obstructive*/complications
Pulmonary Disease, Chronic Obstructive*/diagnosis
Pulmonary Disease, Chronic Obstructive*/epidemiology
Rosacea*/complications
Rosacea*/diagnosis
Rosacea*/epidemiology
Cross-Sectional Studies ; Forced Expiratory Volume ; Humans ; Vital Capacity

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Dexamethasone and p38 MAPK inhibition of cytokine production from human lung fibroblasts.
Autorzy:: Higham A; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.
Singh D; Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, The University of Manchester and Manchester University NHS Foundation Trust, Manchester, UK.; Medicines Evaluation Unit, Manchester, UK.; Pokaż więcej
Źródło:: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2021 Aug; Vol. 35 (4), pp. 714-724. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-Inflammatory Agents/*pharmacology
Dexamethasone/*pharmacology
Fibroblasts/*metabolism
Lung/*metabolism
p38 Mitogen-Activated Protein Kinases/*antagonists & inhibitors
Anti-Inflammatory Agents/therapeutic use ; Cells, Cultured ; Cytokines/metabolism ; Dexamethasone/therapeutic use ; Humans ; Pulmonary Disease, Chronic Obstructive/drug therapy ; p38 Mitogen-Activated Protein Kinases/metabolism

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Clinical relevance of the relaxant effects of roflumilast on human bronchus: potentiation by a long-acting beta-2-agonist.
Autorzy:: Salvator H; Laboratory of Research in Respiratory Pharmacology, V2I - UMR-0092, Université Paris Saclay, Suresnes, France.; Department of Airway Diseases, Respiratory Pharmacology Unit, Hôpital Foch, Suresnes, France.
Naline E; Laboratory of Research in Respiratory Pharmacology, V2I - UMR-0092, Université Paris Saclay, Suresnes, France.; Department of Airway Diseases, Respiratory Pharmacology Unit, Hôpital Foch, Suresnes, France.
Brollo M; Laboratory of Research in Respiratory Pharmacology, V2I - UMR-0092, Université Paris Saclay, Suresnes, France.
Tenor H; TOPADUR Pharma AG, Schlieren, Switzerland.
Grassin-Delyle S; Department of Airway Diseases, Respiratory Pharmacology Unit, Hôpital Foch, Suresnes, France.; INSERM U1173, Infection & Inflammation, Département de Biotechnologie de la Santé, Université Paris-Saclay, Montigny-le-Bretonneux, France.
Devillier P; Laboratory of Research in Respiratory Pharmacology, V2I - UMR-0092, Université Paris Saclay, Suresnes, France.; Department of Airway Diseases, Respiratory Pharmacology Unit, Hôpital Foch, Suresnes, France.; Pokaż więcej
Źródło:: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2021 Aug; Vol. 35 (4), pp. 725-731. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji:: Journal Article
MeSH Terms:: Aminopyridines/*pharmacology
Benzamides/*pharmacology
Bronchi/*drug effects
Bronchodilator Agents/*pharmacology
Phosphodiesterase 4 Inhibitors/*pharmacology
Aminopyridines/administration & dosage ; Aminopyridines/therapeutic use ; Benzamides/administration & dosage ; Benzamides/therapeutic use ; Bronchi/physiology ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/therapeutic use ; Cyclopropanes/administration & dosage ; Cyclopropanes/pharmacology ; Cyclopropanes/therapeutic use ; Female ; Formoterol Fumarate/administration & dosage ; Formoterol Fumarate/pharmacology ; Formoterol Fumarate/therapeutic use ; Humans ; Male ; Middle Aged ; Phosphodiesterase 4 Inhibitors/administration & dosage ; Phosphodiesterase 4 Inhibitors/therapeutic use ; Pulmonary Disease, Chronic Obstructive/drug therapy

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Patient factors predict complications after partial nephrectomy: validation and calibration of the Preoperative Risk Evaluation for Partial Nephrectomy (PREP) score.
Autorzy:: Huynh MJ; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Wang Y; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA.
Joshi M; Harvard Medical School, Boston, MA, USA.
Krasnow R; Department of Urology, MedStar Washington Hospital Center, Washington, DC, USA.
Yu AX; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.
Mossanen M; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Surgery and Public Health, Brigham and Women's Hospital, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.
Chung BI; Department of Urology, Stanford University, Stanford, CA, USA.
Chang SL; Division of Urology, Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Dana-Farber Cancer Institute, Boston, MA, USA.; Pokaż więcej
Źródło:: BJU international [BJU Int] 2021 Mar; Vol. 127 (3), pp. 369-374. Date of Electronic Publication: 2020 Oct 01.
Typ publikacji:: Journal Article; Validation Study
MeSH Terms:: Cardiovascular Diseases/*epidemiology
Kidney Neoplasms/*epidemiology
Kidney Neoplasms/*surgery
Nephrectomy/*adverse effects
Postoperative Complications/*etiology
Age Factors ; Aged ; Area Under Curve ; Calibration ; Comorbidity ; Databases, Factual ; Diabetes Mellitus/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Nephrectomy/statistics & numerical data ; Obesity/epidemiology ; Probability ; Pulmonary Disease, Chronic Obstructive/epidemiology ; ROC Curve ; Renal Insufficiency, Chronic/epidemiology ; Retrospective Studies ; Risk Assessment/methods ; Risk Factors ; Sex Factors ; Smoking/epidemiology

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Can β2-adrenoceptor agonists, anticholinergic drugs, and theophylline contribute to the control of pulmonary inflammation and emphysema in COPD?
Autorzy:: Zhang WH; Department of Physiology, School of Medicine, Shanghai JiaoTong University, Shanghai, China. i_ />Zhang Y
Cui YY
Rong WF
Cambier C
Devillier P
Bureau F
Advenier C
Gustin P; Pokaż więcej
Źródło:: Fundamental & clinical pharmacology [Fundam Clin Pharmacol] 2012 Feb; Vol. 26 (1), pp. 118-34. Date of Electronic Publication: 2011 Nov 02.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:: Bronchodilator Agents/*therapeutic use
Inflammation/*drug therapy
Pulmonary Disease, Chronic Obstructive/*drug therapy
Adrenergic beta-2 Receptor Agonists/administration & dosage ; Adrenergic beta-2 Receptor Agonists/pharmacology ; Adrenergic beta-2 Receptor Agonists/therapeutic use ; Animals ; Bronchodilator Agents/administration & dosage ; Bronchodilator Agents/pharmacology ; Cholinergic Antagonists/administration & dosage ; Cholinergic Antagonists/pharmacology ; Cholinergic Antagonists/therapeutic use ; Disease Progression ; Drug Synergism ; Emphysema/drug therapy ; Emphysema/etiology ; Humans ; Inflammation/etiology ; Inflammation/pathology ; Pulmonary Disease, Chronic Obstructive/physiopathology ; Theophylline/administration & dosage ; Theophylline/pharmacology ; Theophylline/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Prevalence of depressive symptoms in Japanese male patients with chronic obstructive pulmonary disease.
Autorzy:: Hayashi Y; Department of Neuropsychiatry, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
Senjyu H
Iguchi A
Iwai S
Kanada R
Honda S
Ozawa H; Pokaż więcej
Źródło:: Psychiatry and clinical neurosciences [Psychiatry Clin Neurosci] 2011 Feb; Vol. 65 (1), pp. 82-8.
Typ publikacji:: Journal Article
MeSH Terms:: Depression/*etiology
Pulmonary Disease, Chronic Obstructive/*psychology
Age Factors ; Aged ; Aged, 80 and over ; Chi-Square Distribution ; Depression/epidemiology ; Humans ; Japan/epidemiology ; Logistic Models ; Male ; Middle Aged ; Prevalence ; Psychiatric Status Rating Scales ; Pulmonary Disease, Chronic Obstructive/complications ; Severity of Illness Index ; Socioeconomic Factors

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Relapsing Bacillus licheniformis peritonitis in a continuous ambulatory peritoneal dialysis patient.
Autorzy:: Park DJ; Department of Internal Medicine, Gyenongsang National University, Collge of Medicine, Jinju, South Korea.
Yun JC
Baek JE
Jung EY
Lee DW
Kim MA
Chang SH; Pokaż więcej
Źródło:: Nephrology (Carlton, Vic.) [Nephrology (Carlton)] 2006 Feb; Vol. 11 (1), pp. 21-2.
Typ publikacji:: Case Reports; Journal Article; Review
MeSH Terms:: Bacillus*
Pulmonary Disease, Chronic Obstructive*
Gram-Positive Bacterial Infections/*diagnosis
Peritonitis/*diagnosis
Peritonitis/*microbiology
Adult ; Humans ; Male ; Recurrence